New FDI policy – a boon or a bane in disguise?

In their article, Phoenix Legal’s Kripi Kathuria and Ankur Verma discuss why the pharmaceutical industry in India is attracting interest from investors worldwide, noting amongst other things “ever-increasing returns, lowering risk and anticipated multifold growth”.

The increased use of technology has paved its way into our daily lives causing consumers to rely on it for availing even the most unconventional goods and services. This accelerated use of technology ...